An Open-label Study to Evaluate the Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
The primary objective of this study is to evaluate the efficacy and tolerability of ecopipam in reducing stuttering symptoms.
It is hypothesized that ecopipam effectively reduces stuttering symptoms as measured on the SSI-IV total score, the CGI, SSS and OASES.
100 项与 Citrials, Inc. 相关的临床结果
0 项与 Citrials, Inc. 相关的专利(医药)
100 项与 Citrials, Inc. 相关的药物交易
100 项与 Citrials, Inc. 相关的转化医学